Infection for Helicobacter pylori in the provincial consultation of Gastroenterology of the Hospital “Faustino Pérez”, of Matanzas

Authors

Keywords:

, Helicobacter pylori, gastritis, endoscopy

Abstract

Introduction: the infection for Helicobacter pylori is one of the more prevalent in the world; it supposes a significant burden for the sanitary systems, due to the high resistance to antibiotics that it presents for its eradication.
Objective: to determine the clinical epidemiological characteristics of the infection due to Helicobacter pylori in patients treated in the provincial consultation of Gastroenterología.
Materials and methods: an observational, descriptive study was carried out in a universe formed by 167 patients with positive Helicobacter pylori determined by urease test. The variables to consider were age, sex, histologic diagnosis, clinical symptoms and clinical evolution after the specific treatment for Helicobacter pylori. The statistical technique of analysis of frequencies distribution was used.
Results: 59, 6% of the patients was Helicobacter pylori positive with prevalence of the male sex; chronic gastritis was the gastric alteration more associated to the infection. Epigastralgia and abdominal distension were the most frequent symptoms. 49% of the cases evolved in a satisfactory way and only 17% answered bad to the treatment.
Conclusions: a high percent of infection by Helicobacter pylori was found and also a good answer to the used treatment.

Downloads

Download data is not yet available.

References

1. Malfertheiner P, Megraud F, et al. Management of Helicobacter pylori infection-the Maastricht V/Florence Consensus Report. Gut[Internet]. 2017[citado 20/01/20]; 66(1):6-30.Disponible en: https://gut.bmj.com/content/66/1/6.short

2. MINSAP. Anuario estadístico Oficina Nacional de Estadísticas e Información. La Habana: MINSAP; 2018[citado 20/01/20] . Disponible en: http://www.onei.gob.cu/node/14211

3. Fallone CA, Chiba N, Van Zanten SV, et al. The Toronto Consensus for the treatment of Helicobacter pylori infection in adults. Gastroenterology 2016; 151(1):51-69. Citado en PubMed; PMID: 27102658.

4. Graham DY, Laine L. The Toronto Helicobacter pylori Consensus in Context. Gastroenterology 2016; 151: 9-12. Citado en PubMed; PMID:27899015.

5. Bernardini G, Figura N, Ponzetto A, et al. Application of proteomics to the study of Helicobacter pylori and implications for the clinic. Expert Rev Proteomics. 2017 Jun;14(6):477-490. Citado en PubMed; PMID: 28513226.

6. Avalos García R, Morales Díaz M. Romero Bareira SR, et al. Comportamiento del cáncer gástrico avanzado diagnosticado por videoendoscopia en el Hospital “Faustino Pérez Hernández”, Matanzas. Rev Méd Electrón [Internet].2017 May-Jun [citado 20/01/20];39(3). Disponible en: http://www.revmedicaelectronica.sld.cu/index.php/rme/article/view/2072/3441
7. Ministerio de Ciencia, Tecnología y Medio Ambiente. Resolución Nº 103. Reglamento para el establecimiento de los requisitos y procedimientos de seguridad biológica en las instalaciones en las que se hace uso de agentes biológicos y sus productos, organismos y fragmentos de estos con información genética. La Habana. CITMA; 2002[Internet]. 47: 78-89. Disponible en: http://www.sld.cu/galerias/pdf/sitios/insat/r-103-2000-citma.pdf

8. Bravo LE, Cortes A, Carrascal E, et al. Helicobacter pylori: patología y prevalencia en biopsias gástricas en Colombia. Colomb Med[Internet]. 2003[ citado 20/01/20]; 34:124-34. Disponible en: http://colombiamedica.univalle.edu.co/index.php/comedica/article/view/263

9. Simón Correa G, Andrés Felipe Cardona A, Tomás Correa G, et al. Prevalencia de Helicobacter pylori y características histopatológicas en biopsias gástricas de pacientes con síntomas dispépticos en un centro de referencia de Medellín. Rev Colombiana Gastroenterología[Internet].2016[ citado 20/01/20];31(1):9-15.Disponible en: http://www.scielo.org.co/scielo.php?script=sci_arttext&pid=S0120-99572016000100002

10. American Cancer Society. Cáncer de estómago[Internet]. EE UU: American Cancer Society;2018[ citado 20/01/20]. Disponible en: http://www.cancer.org/acs/groups/cid/documents/webcontent/002322-pdf.pdf

11. Jung YS, Park CH, Park JH, et al. Efficacy of Helicobacter pylori eradication therapies in Korea: A systematic review and network metaanalysis. Helicobacter. 2017 Aug ;22(4). Citado en PubMed; PMID: 28425141.

12. Mori G, Nakajima T, Asada K, et al. Incidence of and risk factors for metachronous gastric cancer after endoscopic resection and successful Helicobacter pylori eradication: results of a large-scale, multicenter cohort study in Japan. Gastric Cancer. 2016 Jul;19(3):911-8. Citado en PubMed; PMID: 26420267.

13- Ortega JP, Espino A, Calvo A, et al. Infección por Helicobacter pylori en pacientes sintomáticos con patología gastroduodenal benigna: Análisis de 5.664 pacientes. Rev Med Chile[Internet]. 2010[citado 20/01/20]; 38(5):529-35. Disponible en: https://scielo.conicyt.cl/scielo.php?script=sci_arttext&pid=S0034-98872010000500001

14. Chey WD, Leontiadis GI, Howden CW, et al. ACG Clinical Guideline: Treatment of Helicobacter pylori Infection. Am J Gastroenterol. 2018 Jul;1 13(7):1102. Citado en PubMed; PMID: 29895984.


15. Crespo Ramírez E, González Pérez S, López Vasquez N, Pagarizabal Núñez S. Cáncer gástrico en pacientes atendidos en servicio de endoscopia digestiva. Rev Ciencias Médicas de Pinar del Río[Internet]. 2017 [citado 20/01/20];21(5)661-8. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1561-31942017000500008

16. Choi JM, Kim SG, Choi JM, et al. Effects of Helicobacter pylori eradication for metachronous gastric cáncer prevention: a randomized controlled trial. Gastrointest Endosc[internet]. 2018[citado 20/01/20]; 88(3):475-85. Disponible en: https://www.sciencedirect.com/science/article/abs/pii/S0016510718327020

17. Duquesne Alderete A, Rodríguez Pérez, Orellana Molina Y. Caracterización clínico-epidemiológica-endoscópica-anatomopatológica y microbiológica de pacientes con gastritis. Policlínico 19 de Abril. 2012-2016. Panorama Cubana y Salud.2017; 12 (3):39-45. Disponible en: http://www.redalyc.org/articulo.oa?id=477355406007

18. Stollman N. Helicobacter pylori infection in the era of antibiotic resistence. Gastroenterol Hepatol (N Y). 2016 Feb; 12(2): 122–5. Citado en PubMed; PMID: 27182214

19. Gisbert JP, Romano M, Gravina AG, et al. Helicobacter pylori second-line rescue therapy with levofloxacin- and bismuth-containing quadruple therapy, after failure of standard triple or non-bismuth quadruple treatments. Aliment Pharmacol Ther. 2015 Apr;41(8):768-75. Citado en PubMed; PMID: 25703120.

Downloads

Published

2020-10-14

How to Cite

1.
Morales Díaz M, Pacheco Morales Y, Corrales Alonso S, Laud Martínez PM, Fonseca Infante SM, Secada Cárdenas E. Infection for Helicobacter pylori in the provincial consultation of Gastroenterology of the Hospital “Faustino Pérez”, of Matanzas. Rev Méd Electrón [Internet]. 2020 Oct. 14 [cited 2025 Apr. 13];42(5):1-13. Available from: https://revmedicaelectronica.sld.cu/index.php/rme/article/view/3774

Issue

Vol. 42 No. 5 (2020)

Section

Research article

License

All content published in this journal is Open Access, distributed under the terms of the CC BY-NC 4.0 License.

It allows:

 - Copy and redistribute published material in any medium or format.

 - Adapt the content.

 This will be done under the following terms:

 - Attribute the authors' credits and indicate whether changes were made, in which case it must be in a reasonable way.

 - Non-commercial use.

 - Recognize the journal where it is published.

 The copyrights of each article are maintained, without restrictions.